Len May is the CEO of EndoCanna Health, a biotechnology company that can tailor cannabinoid recommendations to your DNA.
In episode we talked about how people can get vastly different experiences with the same strain and how it all has to do with your epigenetics and your DNA.
We talk about where the terms indica and sativa came from, how how we may approach a new way to name them.
We also talk about the pharmaceuticalization of the cannabis industry and how our best approach may be looking at it as a supplement.
This article was originally published by Rss.com. Read the original article here.
